The Leptomeningeal “Ivy Sign” on Fluid-Attenuated Inversion Recovery MR Imaging in Moyamoya Disease: A Sign of Decreased Cerebral Vascular Reserve?

BACKGROUND AND PURPOSE: Moyamoya disease is an idiopathic occlusive cerebrovascular disorder with abnormal microvascular proliferation. We investigated the clinical utility of leptomeningeal high signal intensity (ivy sign) sometimes seen on fluid-attenuated inversion recovery images in Moyamoya disease. MATERIALS AND METHODS: We examined the relationship between the degree of the ivy sign and the severity of the ischemic symptoms in 96 hemispheres of 48 patients with Moyamoya disease. We classified each cerebral hemisphere into 4 regions from anterior to posterior. In 192 regions of 24 patients, we examined the relationship between the degree of the ivy sign and findings of single-photon emission CT, including the resting cerebral blood flow (CBF) and cerebral vascular reserve (CVR). RESULTS: The degree of the ivy sign showed a significant positive relationship with the severity of the ischemic symptoms (P < .001). Of the 4 regions, the ivy sign was most frequently and prominently seen in the anterior part of the middle cerebral artery region. The degree of the ivy sign showed a negative relationship with the resting CBF (P < .0034) and a more prominent negative relationship with the CVR (P < .001). CONCLUSIONS: The leptomeningeal ivy sign indicates decreased CVR in Moyamoya disease.

[1]  S. Mugikura,et al.  Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. , 2007, Surgical neurology.

[2]  K. Matsumura,et al.  Usefulness of fully automated constant ROI analysis software for the brain: 3DSRT and FineSRT , 2006, Radiation Medicine.

[3]  I. Nagata,et al.  Quantification of the regional cerebral blood flow and vascular reserve in moyamoya disease using split-dose iodoamphetamine I 123 single-photon emission computed tomography. , 2006, Surgical neurology.

[4]  Hiroshi Fukuda,et al.  Database of normal human cerebral blood flow measured by SPECT: I. Comparison between I-123-IMP, Tc-99m-HMPAO, and Tc-99m-ECD as referred with O-15 labeled water PET and voxel-based morphometry , 2006, Annals of nuclear medicine.

[5]  S. Kuribayashi,et al.  Leptomeningeal high signal intensity (ivy sign) on fluid-attenuated inversion-recovery (FLAIR) MR images in moyamoya disease. , 2005, European journal of radiology.

[6]  K. Poskitt,et al.  Predicting Stroke Risk in Pediatric Moyamoya Disease with Xenon-enhanced Computed Tomography , 2004, Neurosurgery.

[7]  Ryo Takeuchi,et al.  [Fully automated ROI analysis software for the brain; 3DSRT]. , 2003, Nihon Hoshasen Gijutsu Gakkai zasshi.

[8]  D. Legemate,et al.  Acetazolamide as a vasodilatory stimulus in cerebrovascular diseases and in conditions affecting the cerebral vasculature , 2003, European journal of neurology.

[9]  S. Higano,et al.  Predominant Involvement of Ipsilateral Anterior and Posterior Circulations in Moyamoya Disease , 2002, Stroke.

[10]  H. Shin,et al.  "Ivy sign" in childhood moyamoya disease: depiction on FLAIR and contrast-enhanced T1-weighted MR images. , 2002, Radiology.

[11]  I Kanno,et al.  Regional Differences in Cerebral Vascular Response to Paco2 Changes in Humans Measured by Positron Emission Tomography , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  M. Maeda,et al.  "Ivy sign" on fluid-attenuated inversion-recovery images in childhood moyamoya disease. , 1999, AJNR. American journal of neuroradiology.

[13]  S. Higano,et al.  The relationship between cerebral infarction and angiographic characteristics in childhood moyamoya disease. , 1999, AJNR. American journal of neuroradiology.

[14]  J. Nakagawara,et al.  Quantification of regional cerebral blood flow and vascular reserve in childhood Moyamoya disease using [123I]IMP-ARG method , 1997, Clinical Neurology and Neurosurgery.

[15]  I. Yamada,et al.  SPECT and MRI evaluations of the posterior circulation in moyamoya disease. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  Y Yonekura,et al.  A Multicenter Validation of Regional Cerebral Blood Flow Quantitation Using [123I]Iodoamphetamine and Single Photon Emission Computed Tomography , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  T. Kuroiwa,et al.  Diffuse leptomeningeal enhancement, "ivy sign," in magnetic resonance images of moyamoya disease in childhood: case report. , 1995, Neurosurgery.

[18]  Y Ichiya,et al.  Time dependency of the acetazolamide effect on cerebral hemodynamics in patients with chronic occlusive cerebral arteries. Early steal phenomenon demonstrated by [15O]H2O positron emission tomography. , 1995, Stroke.

[19]  J. Hatazawa,et al.  Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  N. Kodama,et al.  Cerebrovascular "Moyamoya" Disease , 1971 .

[21]  A Takaku,et al.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. , 1969, Archives of neurology.

[22]  Y. Matsushima,et al.  Analysis of the angiographic findings in cases of childhood moyamoya disease , 2004, Neuroradiology.

[23]  厚生省特定疾患ウイリス動脈輪閉塞症の病因・病態に関する研究班,et al.  厚生省特定疾患ウイリス動脈輪閉塞症の病因・病態に関する研究班研究報告書 = The Research committee on spontaneous occlusion of the circle of willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan annual report , 2000 .

[24]  H. Hoshi,et al.  Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  N. Kodama,et al.  Cerebrovascular "Moyamoya" disease. 2. Collateral routes to forebrain via ethmoid sinus and superior nasal meatus. , 1971, Angiology.